Years will pass before the global economy’s healthcare sector sufficiently leverages AI to build major financial muscle off of it. And even then, industry players are likely to see gains well ahead of hospitals and health systems. 

Pricing transparency report cards for 2024 are out, and the grades for U.S. hospitals have dipped for the first time since the federal government reset the standards in 2021.

As healthcare AI opens new avenues to improve care quality without unduly increasing operational costs, the technology also expands potential exposure to civil and criminal liabilities. And that’s not only for providers but also payers and suppliers.

The American Medical Association lays out eight in-demand AI use cases for which the organization says it has heard physicians “express particular enthusiasm.”

When asked to depict people by various descriptors, the image generator delivered lots of results that were unintentionally hilarious for their wild inaccuracy.

Here’s what people have been saying about Nvidia’s gradual-then-sudden rise to riches—and what it says about expectations around AI in 2024.  

Only 16% of almost three dozen healthcare executives report having a policy for AI governance.

As AI continues infiltrating healthcare at nearly every level, the technology’s potential for good and ill must become—or remain—a preeminent concern for hospital boards of trustees.